Deal-Making

thumbnail
Deal-Making
SK pharmteco secures $1.4bn GLP-1 dealSK pharmteco secures $1.4bn GLP-1 deal

In addition to producing glucagon-like peptide-1 (GLP-1) drugs for an anonymous partner over five years, the Korean firm is consolidating its brands.

byShreeyashi Ojha, Reporter
Dec 19, 2024
|
1 Min Read
thumbnail
Deal-Making
MilliporeSigma to acquire Netherlands-based organoid pioneer HUBMilliporeSigma to acquire Netherlands-based organoid pioneer HUB
byJosh Abbott
Dec 18, 2024
1 Min Read
thumbnail
Facilities & Capacity
Israeli biomanufacturer Scinai expands into US with CDMO subsidiaryIsraeli biomanufacturer Scinai expands into US with CDMO subsidiary
byJosh Abbott
Dec 18, 2024
1 Min Read
thumbnail
Deal-Making
Asahi strengthens autoimmune focus with Chiome partnershipAsahi strengthens autoimmune focus with Chiome partnership
byShreeyashi Ojha
Dec 16, 2024
1 Min Read
thumbnail
Facilities & Capacity
Novo expands EU footprint with $200m Novavax plantNovo expands EU footprint with $200m Novavax plant
byShreeyashi Ojha
Dec 5, 2024
1 Min Read
thumbnail
Deal-Making
ATI and KBI team up to manufacture antagonistic antibody candidateATI and KBI team up to manufacture antagonistic antibody candidate
byJosh Abbott
Dec 5, 2024
1 Min Read
Deal-Making
Intas acquires Udenyca from Coherus BioSciences in potential $558 million deal
Intas acquires Udenyca from Coherus BioSciences in potential $558 million deal
Dec 5, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Big Pharma, big CGT deals: Roche buying Poseida, Novartis buys Kate
Big Pharma, big CGT deals: Roche buying Poseida, Novartis buys Kate
Dec 2, 2024
|
1 Min Read
byDan Stanton, Editorial director
Deal-Making
Halozyme’s $2.1bn Evotec bid: First the ins, now the out
Halozyme’s $2.1bn Evotec bid: First the ins, now the out
Nov 25, 2024
|
1 Min Read
byDan Stanton, Editorial director
Deal-Making
CDMO success stories: News from Lonza, Samsung Bio, Fujifilm
CDMO success stories: News from Lonza, Samsung Bio, Fujifilm
Nov 21, 2024
|
1 Min Read
byDan Stanton, Editorial director
Facilities & Capacity
Affinia and Forge team up to tackle cardiovascular diseases
Affinia and Forge team up to tackle cardiovascular diseases
Nov 15, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Therapeutic Class
Meitheal adds three biosimilars to US offering with new agreement
Meitheal adds three biosimilars to US offering with new agreement
Nov 13, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Novo taps Ascendis in $285m GLP-1 deal
Novo taps Ascendis in $285m GLP-1 deal
Nov 13, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
PE to buy CDMO Avid Bioservices for $1.1 billion
PE to buy CDMO Avid Bioservices for $1.1 billion
Nov 7, 2024
|
1 Min Read
byDan Stanton, Editorial director
Deal-Making
Chime partners with MedPacto for biologic manufacturing
Chime partners with MedPacto for biologic manufacturing
Nov 4, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability
Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability
Oct 30, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Regulations
Letter urges FTC to block Novo’s $16.5bn Catalent purchase
Letter urges FTC to block Novo’s $16.5bn Catalent purchase
Oct 18, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Cellular Origins and Fresenius Kabi partner to drive automation in CGT manufacturing
Cellular Origins and Fresenius Kabi partner to drive automation in CGT manufacturing
Oct 16, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
ReiThera partners with Sabin to send Marburg vaccine to Rwanda
ReiThera partners with Sabin to send Marburg vaccine to Rwanda
Oct 14, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Opencell and Adva partnership seeks to improve CGT manufacturing
Opencell and Adva partnership seeks to improve CGT manufacturing
Oct 9, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Recipharm and Exela collaborate to boost US sterile injectable production
Recipharm and Exela collaborate to boost US sterile injectable production
Oct 9, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Xcellbio and AmplifyBio partner to advance cell-therapy development
Xcellbio and AmplifyBio partner to advance cell-therapy development
Oct 8, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Dark Horse bolsters CGT consulting outreach with BioTechLogic acquisition
Dark Horse bolsters CGT consulting outreach with BioTechLogic acquisition
Oct 4, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Amid BIOSECURE Act, WuXi Apptec and WuXi Biologics explore selling assets
Amid BIOSECURE Act, WuXi Apptec and WuXi Biologics explore selling assets
Oct 3, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Legend Bio and Multiply Labs partner to improve CAR-T manufacturing
Legend Bio and Multiply Labs partner to improve CAR-T manufacturing
Oct 2, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
CompleCure taps AGC for AMDC-based cancer-therapy development
CompleCure taps AGC for AMDC-based cancer-therapy development
Sep 30, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Quell, eXmoor partner to advance autologous CAR-Treg therapies
Quell, eXmoor partner to advance autologous CAR-Treg therapies
Sep 26, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Charles River and Ori Biotech collaborate on CAR-T production
Charles River and Ori Biotech collaborate on CAR-T production
Sep 20, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
MinervaX taps Wacker for clinical and commercial GBS vaccine supply
MinervaX taps Wacker for clinical and commercial GBS vaccine supply
Sep 19, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Bavarian Nordic to send 500,000 doses of mpox vaccine to Africa
Bavarian Nordic to send 500,000 doses of mpox vaccine to Africa
Sep 19, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Kincell secures partnership to produce cell therapy for clinical trials
Kincell secures partnership to produce cell therapy for clinical trials
Sep 17, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Hongene and ReciBioPharm partner to improve gene-editing services
Hongene and ReciBioPharm partner to improve gene-editing services
Sep 16, 2024
|
1 Min Read
byJosh Abbott, Shreeyashi Ojha
Deal-Making
Cellular and 3P partner to bolster CGT manufacturing
Cellular and 3P partner to bolster CGT manufacturing
Sep 13, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Cellares and Sony partner to automate cell therapy manufacturing
Cellares and Sony partner to automate cell therapy manufacturing
Sep 12, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Boehringer Ingelheim bolsters veterinary pipeline with Saiba acquisition
Boehringer Ingelheim bolsters veterinary pipeline with Saiba acquisition
Sep 5, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024